Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13,523,933 | $13,693,591 | $16,241,313 | $10,308,157 |
| Short-Term Investments | $2,595,997 | $1,888,496 | $928,532 | $4,241,069 |
| Receivables | $9,430,022 | $9,697,213 | $8,171,869 | $6,473,831 |
| Inventory | $7,258,649 | $7,537,768 | $6,882,432 | $5,472,315 |
| Other Curr. Assets | $1,682,459 | $951,301 | $5,591,029 | $2,349,573 |
| Total Curr. Assets | $34,491,061 | $33,792,569 | $35,279,178 | $30,424,633 |
| Property Plant & Equip (Net) | $23,410,549 | $23,670,579 | $16,028,093 | $13,283,929 |
| Goodwill | $10,905,083 | $10,851,999 | $10,337,053 | $9,399,987 |
| Intangibles | $19,336,238 | $18,072,690 | $15,925,317 | $13,433,161 |
| Long-Term Investments | $23,269,067 | $25,559,840 | $24,620,519 | $19,679,049 |
| Tax Assets | $757,776 | $1,185,236 | $442,570 | $265,589 |
| Other NC Assets | $5,290,793 | $336,691 | $4,531,177 | $6,807,443 |
| Total NC Assets | $82,969,507 | $79,677,036 | $71,884,729 | $62,869,158 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $117,460,567 | $113,469,605 | $107,163,907 | $93,293,791 |
| Liabilities | – | – | – | – |
| Payables | $5,997,385 | $6,159,619 | $6,284,041 | $5,063,693 |
| Short-Term Debt | $18,711,315 | $14,728,454 | $11,931,537 | $14,547,617 |
| Tax Payable | $560,735 | $250,629 | $929,836 | $727,522 |
| Deferred Revenue | $0 | $0 | $1,544,763 | $8,170,066 |
| Other Curr. Liab. | $12,183,235 | $12,618,881 | $14,152,656 | $7,825,782 |
| Total Curr. Liab. | $37,452,669 | $33,757,584 | $33,298,069 | $29,309,945 |
| LT Debt | $12,985,468 | $15,554,512 | $12,844,861 | $9,697,430 |
| Deferred Rev, NC | $657,891 | $0 | $632,433 | $512,806 |
| Deferred Tax Liab, NC | $3,245,159 | $0 | $3,362,940 | $3,129,746 |
| Other NC Liab. | $3,185,652 | $7,541,248 | $3,038,261 | $2,268,299 |
| Total NC Liab. | $20,074,169 | $23,095,761 | $19,756,928 | $15,608,281 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2,541,968 | $2,049,589 | $744,993 | $648,360 |
| Total Liabilities | $57,526,838 | $56,853,344 | $53,054,998 | $44,918,227 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2,671,326 | $2,672,399 | $2,672,157 | $2,562,899 |
| Retained Earnings | $26,553,059 | $24,542,511 | $26,169,781 | $21,039,554 |
| AOCI | $0 | -$1,300,090 | -$1,198,364 | $4,411,311 |
| Other Equity | $18,036,722 | $19,769,942 | $16,938,883 | $11,189,683 |
| Total Equity | $47,261,107 | $45,684,762 | $44,582,458 | $39,191,949 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $12,672,622 | $10,931,499 | $9,526,452 | $9,183,615 |
| Total Liab. & Tot. Equity | $117,460,567 | $113,469,605 | $107,163,907 | $93,293,791 |
| Net Debt | $18,172,850 | $16,589,376 | $8,535,085 | $13,936,890 |